SCHEMBL5163052

SCHEMBL5163052

O=C1CCC(c2ccccc2C(=O)O)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.45
ALOX15 P16050 1/20 0.45
CYP2C9 P11712 1/20 0.45
IKBKB O14920 1/20 0.44
ESR2 Q92731 2/20 0.42
MLYCD O95822 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
KDM4E B2RXH2 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
HMGB1 P09429 1/20 0.39
HPGD P15428 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA7 P43166 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4109572 0.87 ALDH1A1 (0.54) ALDH1A1ALOX15CYP2C9MLYCDL3MBTL1
SCHEMBL30175300 0.87 ALDH1A1 (0.54) ALDH1A1ALOX15CYP2C9MLYCDL3MBTL1
SCHEMBL10457353 0.87 ALDH1A1 (0.54) ALDH1A1ALOX15CYP2C9MLYCDL3MBTL1
Hydrochloric Acid SCHEMBL29705669 0.85 ALDH1A1 (0.52) ALDH1A1ALOX15CYP2C9MLYCDL3MBTL1
SCHEMBL19993861 0.84 IKBKB (0.52) ALDH1A1IKBKBESR2MAPTKDM4E
SCHEMBL7882968 0.84 ESR2 (0.44) ALDH1A1ALOX15IKBKBESR2CYP2C19
SCHEMBL2731512 0.83 ALDH1A1 (0.50) ALDH1A1ALOX15CYP2C9MLYCDMAPT
SCHEMBL3634253 0.83 ALDH1A1 (0.50) ALDH1A1ALOX15CYP2C9MLYCDMAPT
SCHEMBL10878096 0.81 ALDH1A1 (0.48) ALDH1A1ALOX15CYP2C9MLYCDL3MBTL1
SCHEMBL50486 0.81 PTGDR2 (0.53) ALDH1A1ALOX15CYP2C9CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3788042-A1 BCL-2 INHIBITORS BeiGene, Ltd. (KY) 2021-03-10 EP disclosed
EP-3515914-A1 NOVEL 5 or 8-SUBSTITUTED IMIDAZO [1, 5-a]PYRIDINES AS SELECTIVE INHIBITORS OF INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES BeiGene, Ltd. (KY) 2019-07-31 EP disclosed
WO-2018054365-A1 NOVEL 5 or 8-SUBSTITUTED IMIDAZO [1, 5-a] PYRIDINES AS SELECTIVE INHIBITORS OF INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES BEIGENE, LTD. (KY) 2018-03-29 WO disclosed
EP-1511722-B1 PHENYLCYCLOHEXYLPROPANOLAMINE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION THEREOF SANOFI AVENTIS (FR) 2007-10-03 EP disclosed
EP-1511728-B1 OXOPHENYL-CYCLOHEXYL-PROPANOLAMINE DERIVATIVES, PRODUCTION AND USE THEREOF IN THERAPEUTICS SANOFI AVENTIS (FR) 2007-03-14 EP disclosed
EP-1511728-A2 OXOPHENYL-CYCLOHEXYL-PROPANOLAMINE DERIVATIVES, PRODUCTION AND USE THEREOF IN THERAPEUTICS Sanofi-Aventis (FR) 2005-03-09 EP disclosed
EP-1511722-A1 PHENYLCYCLOHEXYLPROPANOLAMINE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION THEREOF Sanofi-Aventis (FR) 2005-03-09 EP disclosed
WO-2003099772-A1 PHENYLCYCLOHEXYLPROPANOLAMINE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION THEREOF SANOFI-AVENTIS (FR) 2003-12-04 WO disclosed
WO-2003099819-A2 OXOPHENYL-CYCLOHEXYL-PROPANOLAMINE DERIVATIVES, PRODUCTION AND USE THEREOF IN THERAPEUTICS SANOFI-AVENTIS (FR) 2003-12-04 WO disclosed